Effects of Obesity on Pharmacokinetics
Top Cited Papers
- 1 September 2000
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 39 (3) , 215-231
- https://doi.org/10.2165/00003088-200039030-00004
Abstract
Obesity is a worldwide problem, with major health, social and economic implications. The adaptation of drug dosages to obese patients is a subject of concern, particularly for drugs with a narrow...Keywords
This publication has 65 references indexed in Scilit:
- Clinical Pharmacokinetics of SevofluraneClinical Pharmacokinetics, 1999
- Pharmacokinetics of β‐adrenoceptor blockers in obese and normal volunteersBritish Journal of Clinical Pharmacology, 1997
- Lean Body Mass as a Predictor of Drug DosageClinical Pharmacokinetics, 1994
- Clinical Pharmacokinetics of FluoxetineClinical Pharmacokinetics, 1994
- Clinical Pharmacokinetics of Drugs in ObesityClinical Pharmacokinetics, 1993
- Nicotine Pharmacokinetics of Nicoderm® (Nicotine Transdermal System) in Women and Obese Men Compared With Normal‐Sized MenThe Journal of Clinical Pharmacology, 1993
- Pharmacokinetics and Pharmacodynamics of Vecuronium in the Obese Surgical PatientAnesthesia & Analgesia, 1992
- Effect of Acute and Chronic Exercise on Hepatic Drug MetabolismClinical Pharmacokinetics, 1985
- Obesity and cardiac function.Circulation, 1981
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976